Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
NBIX Neurocrine Biosciences
- 126.700
- -0.090-0.07%
Close Dec 13 16:00 ET
- 128.470
- +1.770+1.40%
Post 20:01 ET
12.83BMarket Cap33.79P/E (TTM)
127.050High125.610Low781.66KVolume126.700Open126.790Pre Close98.84MTurnover0.78%Turnover Ratio51.30P/E (Static)101.25MShares157.98052wk High4.72P/B12.68BFloat Cap110.95052wk Low--Dividend TTM100.08MShs Float157.980Historical High--Div YieldTTM1.14%Amplitude1.940Historical Low126.450Avg Price1Lot Size
Neurocrine Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24.72%622.1M | 30.37%590.2M | 22.57%515.3M | 26.76%1.89B | 25.05%515.2M | 28.59%498.8M | 19.70%452.7M | 35.35%420.4M | 31.34%1.49B | 32.05%412M |
| Operating revenue | 24.72%622.1M | 30.37%590.2M | 22.57%515.3M | 26.76%1.89B | 25.05%515.2M | 28.59%498.8M | 19.70%452.7M | 35.35%420.4M | 31.34%1.49B | 32.05%412M |
| Cost of revenue | -28.57%8M | -20.00%9.2M | -11.76%7.5M | 71.12%39.7M | 10.39%8.5M | 83.61%11.2M | 139.58%11.5M | 84.78%8.5M | 62.24%23.2M | 87.80%7.7M |
| Gross profit | 25.94%614.1M | 31.69%581M | 23.28%507.8M | 26.06%1.85B | 25.33%506.7M | 27.71%487.6M | 18.16%441.2M | 34.61%411.9M | 30.94%1.47B | 31.31%404.3M |
| Operating expense | 23.93%429.3M | 17.82%433.1M | 5.31%402.5M | 19.41%1.45B | 18.44%356.4M | 17.82%346.4M | 15.34%367.6M | 26.18%382.2M | 33.48%1.22B | 23.37%300.9M |
| Selling and administrative expenses | 14.74%234.3M | 9.11%242M | 0.16%243.1M | 17.92%887.6M | 19.68%218.9M | 9.61%204.2M | 21.33%221.8M | 20.93%242.7M | 29.04%752.7M | 16.87%182.9M |
| Research and development costs | 37.13%195M | 31.07%191.1M | 14.27%159.4M | 21.82%565M | 16.53%137.5M | 32.03%142.2M | 7.28%145.8M | 36.50%139.5M | 41.36%463.8M | 35.01%118M |
| Operating profit | 30.88%184.8M | 100.95%147.9M | 254.55%105.3M | 58.55%394.8M | 45.36%150.3M | 60.82%141.2M | 34.55%73.6M | 858.06%29.7M | 19.83%249M | 61.56%103.4M |
| Net non-operating interest income expense | -49.7M | -8,063.64%-89.8M | 35.21%-4.6M | 0 | 57.69%-1.1M | 72.48%-7.1M | 83.33%-1.1M | |||
| Non-operating interest expense | ---- | --49.7M | 8,063.64%89.8M | -35.21%4.6M | ---- | ---- | --0 | -57.69%1.1M | -72.48%7.1M | -83.33%1.1M |
| Other net income (expense) | 121.48%5.5M | -99.17%400K | 114.40%19M | -107.50%-58.1M | 236.54%52.5M | -326.55%-25.6M | 163.32%48M | -731.10%-131.9M | 65.26%-28M | 121.91%15.6M |
| Gain on sale of security | 125.39%6.5M | -93.96%2.9M | 108.33%25M | 104.29%85.8M | 236.54%52.5M | -326.55%-25.6M | 927.59%48M | -42.58%12M | 70.04%42M | -46.39%15.6M |
| Special income (charges) | ---1M | ---2.5M | 95.83%-6M | -105.57%-143.9M | --0 | --0 | --0 | ---143.9M | 33.52%-70M | --0 |
| -Less:Other special charges | --1M | --2.5M | -95.83%6M | 105.57%143.9M | --0 | ---- | ---- | --143.9M | -33.52%70M | --0 |
| Income before tax | 64.62%190.3M | -18.91%98.6M | 133.40%34.5M | 55.26%332.1M | 68.11%198.2M | 18.08%115.6M | 621.89%121.6M | -582.71%-103.3M | 110.95%213.9M | 954.35%117.9M |
| Income tax | 86.15%60.5M | 28.74%33.6M | 66.67%-8.9M | 38.72%82.4M | 74.74%50.5M | 10.54%32.5M | 507.81%26.1M | -456.00%-26.7M | 403.39%59.4M | 544.62%28.9M |
| Net income | 56.20%129.8M | -31.94%65M | 156.66%43.4M | 61.62%249.7M | 65.96%147.7M | 21.31%83.1M | 665.09%95.5M | -651.08%-76.6M | 72.43%154.5M | 1,319.18%89M |
| Net income continuous Operations | 56.20%129.8M | -31.94%65M | 156.66%43.4M | 61.62%249.7M | 65.96%147.7M | 21.31%83.1M | 665.09%95.5M | -651.08%-76.6M | 72.43%154.5M | 1,319.18%89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 56.20%129.8M | -31.94%65M | 156.66%43.4M | 61.62%249.7M | 65.96%147.7M | 21.31%83.1M | 665.09%95.5M | -651.08%-76.6M | 72.43%154.5M | 1,319.18%89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 56.20%129.8M | -31.94%65M | 156.66%43.4M | 61.62%249.7M | 65.96%147.7M | 21.31%83.1M | 665.09%95.5M | -651.08%-76.6M | 72.43%154.5M | 1,319.18%89M |
| Basic earnings per share | 50.59%1.28 | -34.69%0.64 | 154.43%0.43 | 59.01%2.56 | 63.04%1.5 | 18.06%0.85 | 644.44%0.98 | -626.67%-0.79 | 69.47%1.61 | 1,250.00%0.92 |
| Diluted earnings per share | 51.22%1.24 | -33.68%0.63 | 153.16%0.42 | 58.33%2.47 | 63.64%1.44 | 18.84%0.82 | 627.78%0.95 | -664.29%-0.79 | 69.57%1.56 | 1,200.00%0.88 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.